Central Nervous System (CNS) Disorders and Medications

Jul 7, 2024

Central Nervous System (CNS) Disorders and Medications

Overview

  • Topic: Central nervous system disorders and medications used for treatment.
  • Focus Areas: How CNS functions, communication between neurons, definitions, and classifications of CNS disorders.

CNS Communication

  • Components: Brain, Spinal Cord, Neurons
  • Function: Signal transmission via action potentials (electrical charge) through nerve cells
    • Movement of sodium and potassium ions creates action potentials
    • Release of neurotransmitters at synapse
  • Neurotransmitters: Chemical messengers released from one neuron to receptor sites on another
    • Selective release and response by different neurotransmitters and receptor sites

Important Neurotransmitters

  • GABA: Inhibitory neurotransmitter; slows down responses creating a calming effect.
    • Conditions: Low levels linked to anxiety, seizures, bipolar disorder, impulse control issues.
  • Serotonin: Influences mood, sleep, temperature regulation, libido.
    • Related Medications: SSRIs (Selective Serotonin Reuptake Inhibitors) for depression.
  • Dopamine: Impacts motor responses, cognition, and sympathetic nervous system functions (e.g., blood pressure, heart rate).
    • Conditions: ADHD, schizophrenia, Parkinson's disease.
  • Norepinephrine & Epinephrine: Sympathetic adrenergic system role, affects alertness, mood, anxiety.
    • Conditions: Imbalances can lead to depression, anxiety, panic attacks.

Synaptic Process

  • Action at Synapse: Neurotransmitters released from presynaptic neuron to bind on the postsynaptic neuron.
    • Excess Neurotransmitters: Diffusion, reuptake by the presynaptic neuron, or breakdown by enzymes (e.g., Monoamine oxidase - MAO)

CNS Disorders and Associated Medication Classes

Anxiety

  • Description: Mood and behavior disturbances impacting ADLs.
  • Symptoms: Physical issues (aches, GI upset), racing heart, trembling, sweating, difficulty concentrating, emotional disturbances (crying, agitation).
  • Treatment: Pharmacological (medications), Non-pharmacological (relaxation techniques, psychotherapy, support groups).

Depression

  • Description: Clinical depression involves a collection of 5 or more markers consistently impacting ADLs.
  • Symptoms: Suicidal ideation is a major risk; physical, emotional, and psychological markers.
  • Treatment: Medications, Psychotherapy, Group Therapy, Electroconvulsive Therapy (ECT).

Bipolar Disorder

  • Description: Drastic mood swings between manic and depressive phases.
  • Symptoms: Hyperactivity, no need for sleep, mood swings, manic high and depressive low periods.
  • Treatment: Medications, Psychotherapy, ECT, Group Therapy.

Schizophrenia

  • Description: Breakdown of reality connection; usually appears between ages 15-30.
  • Symptoms: Delusions, hallucinations, personal care neglect, energy decrease.
    • Types of Symptoms: Positive (delusions, hallucinations), Negative (apathy, lack of motivation), Cognitive (poor decision making, memory loss).
  • Treatment: Symptom control, pharmacological and non-pharmacological interventions.

ADHD

  • Description: Hyperactivity, inability to concentrate, emotional control issues.

Seizures

  • Description: Abnormal neuron activity; hyperexcitable neurons causing massive firing.
  • Types:
    • Partial Seizures: Simple (one hemisphere, one area affected), Complex (cognitive impairment).
    • Generalized Seizures: Involves both hemispheres, affects motor and cognitive functions.
    • Status Epilepticus: Continuous seizure activity, life-threatening.

Parkinson's Disease

  • Description: Chronic progressive disorder, breakdown of myelin sheath on neurons
  • Symptoms: Tremors, slow movement (bradykinesia), shuffling gait, stooped posture, mood swings.
  • Neurotransmitter Involved: Dopamine, particularly in extra-pyramidal system.
  • Treatment: Focus on dopamine availability and function.

Next Steps

  • Future videos will discuss individual disorders and related drug classifications for pharmacological treatment.